SureGene’s personalized medicine treatment was found to be unpatentable under Section 101 subject matter eligibility and the standards set in Mayo Collaborative Services v. Prometheus Labs., Inc. 566 U.S. 66 (2012).… Read More Narrowing of Section 101 Subject Matter Eligibility in ex parte Timothy